Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03199638 · ClinicalTrials.gov registry record · NA

Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes

A NA study, sponsored by Nemours Children's Clinic.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT03199638 is a NA study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03199638, a NA study, has completed, sponsored by Nemours Children's Clinic.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

This project will assess the feasibility and efficacy of the use of exercise and dietary supplementation with a non essential amino acid - glutamine - a component of most protein supplements, on the regulation of plasma glucose homeostasis in a clinical setting of children with type 1 diabetes (T1D). The study specifically targets patients in puberty as this period is associated with a physiological decline in insulin sensitivity, the latter often associated with poor control. Although physical exercise has long been known to exert beneficial effects on metabolism, lack of time is the most common reason perceived as preventing the performance of exercise in both healthy and diabetic subjects. In earlier studies, the investigators showed that oral supplementation with glutamine, a non essential amino acid given prior to exercise decreases overnight post-exercise blood glucose in adolescents with T1D. Hence, the objective of the current study is to investigate if a novel way of exercising, such as performing 6 short bouts of just 1 min each of intense exercise ('exercise snacks') 30 min before meals, with or without glutamine, improves glycemic control in adolescents with T1D. Designing innovative ways to improve diabetes control in adolescents is highly desirable. The specific aim of the project is to determine whether the sustained use of the proposed exercise snacks with or without glutamine results in diminished glycemic variability and/or improved glucose control

Interventions

  • BEHAVIORAL Exercise
  • DRUG Glutamine vs. Placebo

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2016-04-01
Est. Completion 2017-06-30
Phase NA

Sponsor

Nemours Children's Clinic

108 total trials

What the Registry Record Tells You About NCT03199638

The ClinicalTrials.gov registry entry for NCT03199638 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.

NCT03199638 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03199638 about?

NCT03199638 is a clinical study titled "Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes". This project will assess the feasibility and efficacy of the use of exercise and dietary supplementation with a non essential amino acid - glutamine - a component of most protein supplements, on the regulation of plasma glucose homeostasis in a clinical setting of children with type 1 diabetes (T1D)...

What is the current status of trial NCT03199638?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-04-01. Estimated completion is 2017-06-30.

What interventions are being tested in trial NCT03199638?

The interventions under investigation include: Exercise (BEHAVIORAL), Glutamine vs. Placebo (DRUG).

Who is sponsoring clinical trial NCT03199638?

This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.